| 000 | 01498 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511180549.0 | ||
| 264 | 0 | _c19921228 | |
| 008 | 199212s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00101a008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLabaudinière, R | |
| 245 | 0 | 0 |
_aomega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cNov 1992 |
||
| 300 |
_a4315-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarboxylic Acids _xchemical synthesis |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukotriene B4 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xmetabolism |
| 650 | 0 | 4 | _aReceptors, Leukotriene B4 |
| 650 | 0 | 4 |
_aSpleen _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTetrazoles _xchemical synthesis |
| 700 | 1 | _aDereu, N | |
| 700 | 1 | _aCavy, F | |
| 700 | 1 | _aGuillet, M C | |
| 700 | 1 | _aMarquis, O | |
| 700 | 1 | _aTerlain, B | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 35 _gno. 23 _gp. 4315-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00101a008 _zAvailable from publisher's website |
| 999 |
_c1339536 _d1339536 |
||